A new deal between GNS Healthcare Inc. and Covance Inc. to develop predictive clinical trial models for diabetes is one example of how big data tools are being applied to drug development.

Last week, GNS and the CRO partnered to develop computer models to predict the likelihood of a therapy's success based on available safety and efficacy data, with an initial focus on Type II diabetes.